Suchergebnisse - "Jin, Yinzhu"

PubPharm (80)

11

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis

enthalten in: ACR Open Rheumatology | 2023

von Jin, Y. | Liu, J. | Desai, R. | +1

12

Comparison of EHR Data‐Completeness in Patients with Different Types of Medical Insurance Coverage in the United States

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Anand, P. | Zhang, Y. | Merola, D. | +5

13

Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study

enthalten in: Clinical rheumatology | 2022

von Ingrasciotta, Y. | Jin, Y. | Foti, S. | +5

14

Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis

enthalten in: Arthritis care & research | 2022

von Jin, Y. | Lee, H. | Lee, M. | +4

15

Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases : a cohort study: Classification: Epidemiology

enthalten in: The British journal of dermatology | 2022

von Schneeweiss, M. | Kirchgesner, J. | Wyss, R. | +7

CommentIn: Br J Dermatol. 2022 Nov;187(5):631-632. - PMID 35975655

16

Rotenone induces hepatotoxicity in rats by activating the mitochondrial pathway of apoptosis

enthalten in: Toxicology mechanisms and methods | 2022

von Wang, H. | Huo, M. | Jin, Y. | +4

17

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

enthalten in: Nature communications | 2022

von Wang, S. | Sreedhara, S. | Schneeweiss, S. | +69

18

Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement

enthalten in: Arthritis care & research | 2022

von Gopalakrishnan, C. | Desai, R. | Franklin, J. | +7

19

Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA : A Cohort Study from Longitudinal Electronic Health Records

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2022

von Jin, Y. | Landon, J. | Krueger, W. | +3

20

Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records

enthalten in: BioDrugs | 2022

von Jin, Y. | Landon, J. | Krueger, W. | +3